Orser Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$3.42M |
| 2 |
McDonald's
MCD
|
+$1.08M |
| 3 |
Vanguard Morningstar Value ETF
VTV
|
+$1.08M |
| 4 |
Reliance Steel & Aluminium
RS
|
+$1.04M |
| 5 |
Merck
MRK
|
+$1.01M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cullen/Frost Bankers
CFR
|
+$3.1M |
| 2 |
Occidental Petroleum
OXY
|
+$2.7M |
| 3 |
Sherwin-Williams
SHW
|
+$208K |
| 4 |
Honeywell
HON
|
+$30.1K |
| 5 |
Microsoft
MSFT
|
+$20.4K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.06% |
| 2 | Healthcare | 19.45% |
| 3 | Consumer Staples | 9.35% |
| 4 | Consumer Discretionary | 8.04% |
| 5 | Industrials | 7.9% |
Similar funds
Orser Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Orser Capital Management held 54 positions worth $88.7M, up 28% from $69.3M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Orser Capital Management deployed $9.79M of net new capital in Q1 2023, opening 7 new positions and adding to 22 existing holdings. Its largest new stake was Edwards Lifesciences: 43,461 shares worth $3.6M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Staples.
On the sell side, the largest reduction was Honeywell, an estimated $30.1K trimmed.
- Orser Capital Management's largest Q1 2023 buy was Edwards Lifesciences: 43,461 shares worth $3.6M.
- Orser Capital Management added most to Vanguard Morningstar Value ETF in Q1 2023, an estimated $1.08M increase.
- Orser Capital Management's biggest Q1 2023 reduction was Honeywell, cutting an estimated $30.1K.
- Orser Capital Management fully exited Cullen/Frost Bankers in Q1 2023, selling an estimated $3.1M.
- Orser Capital Management's ten largest holdings make up 50% of its $88.7M portfolio in Q1 2023.
- Orser Capital Management opened 7 new positions and closed 3 in Q1 2023.
- Orser Capital Management's portfolio value rose 28% quarter-over-quarter to $88.7M.
Based on Orser Capital Management's 13F filing for Q1 2023, filed 11 Apr 2023.